EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Basic:
Net income attributable to Edwards Lifesciences Corporation	$ 384.9	$ 343.5	$ 1,032.5	$ 1,123.5
Weighted-average shares outstanding (in shares)	607.0	619.8	607.2	621.0
Basic earnings per share (in dollars per share)	$ 0.63	$ 0.55	$ 1.70	$ 1.81
Diluted:
Net income attributable to Edwards Lifesciences Corporation	$ 384.9	$ 343.5	$ 1,032.5	$ 1,123.5
Weighted-average shares outstanding (in shares)	607.0	619.8	607.2	621.0
Dilutive effect of stock plans (in shares)	2.5	4.7	3.0	5.9
Dilutive weighted-average shares outstanding (in shares)	609.5	624.5	610.2	626.9
Diluted earnings per share (in dollars per share)	$ 0.63	$ 0.55	$ 1.69	$ 1.79